This preview shows pages 1–2. Sign up to view the full content.
This preview has intentionally blurred sections. Sign up to view the full version.View Full Document
Unformatted text preview: 3) ESR Treatment o Severe flares IV cyclophosphamide + prednisalone o Cutaneous symptoms reduce sun exposure. Topical steroids. o Maintenance NSAIDs + hydroxychloroquine (SE retinopathy) for joint and skin symptoms. Azathioprine/methotrexate can be used as steroid sparing agents. Prognosis o 80% survival at 15yrs. o Increased risk of cardiovascular disease and osteoporosis. Prevention Although not fully understood, because SLE is believed to have a genetic component it is difficult to prevent. Management consists of treating the symptoms as they becomes apparent....
View Full Document
- Fall '10